UBS Group
CRNC icon

UBS Group’s Cerence CRNC Stock Holding History

UBS Group’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$501K Sell
79,394
-61,988
-44% -$558K ﹤0.01% 6085
2025
Q4 		$1.51M Sell
141,382
-45,256
-24% -$497K ﹤0.01% 5214
2025
Q3 		$2.33M Buy
186,638
+96,922
+108% +$993K ﹤0.01% 4811
2025
Q2 		$916K Sell
89,716
-333,009
-79% -$2.93M ﹤0.01% 5524
2025
Q1 		$3.34M Buy
422,725
+278,111
+192% +$3.42M ﹤0.01% 4211
2024
Q4 		$1.14M Buy
144,614
+21,653
+18% +$109K ﹤0.01% 5204
2024
Q3 		$387K Buy
122,961
+12,264
+11% +$36.1K ﹤0.01% 5412
2024
Q2 		$313K Buy
110,697
+54,646
+97% +$389K ﹤0.01% 5361
2024
Q1 		$883K Sell
56,051
-1,986
-3% -$33.6K ﹤0.01% 4698
2023
Q4 		$1.14M Buy
58,037
+19,796
+52% +$344K ﹤0.01% 4374
2023
Q3 		$779K Sell
38,241
-5,176
-12% -$130K ﹤0.01% 4302
2023
Q2 		$1.27M Buy
43,417
+24,733
+132% +$678K ﹤0.01% 4006
2023
Q1 		$525K Buy
18,684
+8,077
+76% +$207K ﹤0.01% 4645
2022
Q4 		$197K Sell
10,607
-703
-6% -$12K ﹤0.01% 5468
2022
Q3 		$179K Buy
11,310
+4,145
+58% +$93.1K ﹤0.01% 5190
2022
Q2 		$181K Sell
7,165
-7,713
-52% -$231K ﹤0.01% 5006
2022
Q1 		$537K Sell
14,878
-31,932
-68% -$1.57M ﹤0.01% 4634
2021
Q4 		$3.59M Buy
46,810
+11,506
+33% +$1.01M ﹤0.01% 3194
2021
Q3 		$3.39M Sell
35,304
-2,144
-6% -$234K ﹤0.01% 3097
2021
Q2 		$4M Buy
37,448
+9,714
+35% +$956K ﹤0.01% 2918
2021
Q1 		$2.48M Buy
27,734
+5,682
+26% +$625K ﹤0.01% 3340
2020
Q4 		$2.21M Sell
22,052
-3,576
-14% -$267K ﹤0.01% 3321
2020
Q3 		$1.25M Sell
25,628
-10,943
-30% -$525K ﹤0.01% 3477
2020
Q2 		$1.49M Buy
36,571
+28,897
+377% +$830K ﹤0.01% 3152
2020
Q1 		$118K Sell
7,674
-601
-7% -$12.6K ﹤0.01% 5139
2019
Q4 		$187K Buy
+8,275
New +$136K ﹤0.01% 5648

Other funds holding CRNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group's CRNC Position: Q1 2026 in Review

UBS Group reduced its Cerence (CRNC) stake by 44% in Q1 2026, selling an estimated $558K and leaving 79,394 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #6085.

UBS Group first reported a position in CRNC in Q4 2019 and has held it in 26 quarters since. The position peaked at $4M in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.

  • UBS Group held 79,394 shares of Cerence worth $501K as of Q1 2026.
  • UBS Group sold 61,988 Cerence shares in Q1 2026, an estimated $558K.
  • Cerence made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6085 holding.
  • UBS Group first reported a position in Cerence in Q4 2019 and has held it in 26 quarters since.
  • UBS Group's Cerence position peaked at $4M in Q2 2021.
  • 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.